RetinaCME
CME

Neovascular AMD: The Drier the Better or Just a Bit Wetter?

Author(s)/Faculty: Nancy M Holekamp, MD; Pauline T Merrill, MD
Release Date: 10/8/2019Expiration Date: 10/7/2020
Credit Type: CMENumber of Credits: 0.5
Content Type: LectureProvider:
The presence of retinal fluid as measured by optical coherence tomography guides decision-making for the treatment of patients with neovascular age-related macular degeneration (nAMD), with the goal of therapy being the elimination of these fluids. However, many pinnacle trials assessing anti-vascular endothelial growth factor (anti-VEGF) therapy for nAMD have not found a consistent correlation between fluid reduction or elimination and visual outcomes; while accumulating evidence strongly suggests that different fluid compartments in the retina may have different roles in nAMD. In this recorded educational symposium, experts in the field assess evidence regarding the effects of different retinal fluid compartments on the progression of nAMD as well as evaluate the evidence regarding visual and anatomic outcomes produced by available and emerging anti-VEGF therapies in the treatment of patients with nAMD.